Ascend Wellness Holdings (AAWH) EBIT Growth (1y) (2021 - 2026)
Ascend Wellness Holdings (AAWH) EBIT Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -150.77% |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | -10.00% |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | -0.93% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | -9.25% |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | -97.30% |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 4.05% |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 12.73% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Ascend Wellness Holdings | 83.23 Mn | 16.23 Mn | 45.49 Mn | 626.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 626.95% |
| Mar 31, 2026 | 2.41% |
| Dec 31, 2025 | -381.58% |
| Sep 30, 2025 | 45.18% |
| Jun 30, 2025 | 34.17% |
| Mar 31, 2025 | -3.46% |
| Dec 31, 2024 | 981.21% |
| Sep 30, 2024 | -168.14% |
| Jun 30, 2024 | 80.94% |
| Mar 31, 2024 | 909.80% |
| Dec 31, 2023 | -89.52% |
| Sep 30, 2023 | 43.20% |
| Jun 30, 2023 | -1,219.83% |
| Mar 31, 2023 | 101.73% |
| Dec 31, 2022 | 836.25% |
| Sep 30, 2022 | -78.67% |
| Jun 30, 2022 | -115.50% |
| Mar 31, 2022 | 53.80% |
| Dec 31, 2021 | -116.43% |
| Sep 30, 2021 | 246.45% |